When and how to switch between oral antiplatelet therapies

Recommendation 15. We suggest against switching the P2Y12 inhibitor initially selected at hospital discharge unless there is a compelling clinical reason to do so (eg, stent thrombosis, CV event, bleeding, or significant side effects/intolerance) (Weak Recommendation; Low-Quality Evidence).